Literature DB >> 16740006

Diabetic foot ulcers: practical treatment recommendations.

Michael Edmonds1.   

Abstract

When treating diabetic foot ulcers it is important to be aware of the natural history of the diabetic foot, which can be divided into five stages: stage 1, a normal foot; stage 2, a high risk foot; stage 3, an ulcerated foot; stage 4, an infected foot; and stage 5, a necrotic foot. This covers the entire spectrum of foot disease but emphasises the development of the foot ulcer as a pivotal event in stage 3, which demands urgent and aggressive management. Diabetic foot care in all stages needs multidisciplinary management to control mechanical, wound, microbiological, vascular, metabolic and educational aspects. Achieving good metabolic control of blood glucose, lipids and blood pressure is important in each stage, as is education to teach proper foot care appropriate for each stage. Ideally, it is important to prevent the development of ulcers in stages 1 and 2. In stage 1, the normal foot, it is important to encourage the use of suitable footwear, and to educate the patient to promote healthy foot care and footwear habits. In stage 2, the foot has developed one or more of the following risk factors for ulceration: neuropathy, ischaemia, deformity, swelling and callus. The majority of deformities can be accommodated in special footwear and as callus is an important precursor of ulceration it should be treated aggressively, especially in the neuropathic foot. In stage 3, ulcers can be divided into two distinct entities: those in the neuropathic foot and those in the neuroischaemic foot. In the neuropathic foot, ulcers commonly develop on the plantar surface of the foot and the toes, and are associated with neglected callus and high plantar pressures. In the neuroischaemic foot, ulcers are commonly seen around the edges of the foot, including the apices of the toes and back of the heel, and are associated with trauma or wearing unsuitable shoes. Ulcers in stage 3 need relief of pressure (mechanical control), sharp debridement and dressings (wound control), and neuroischaemic foot ulcers may need vascular intervention (vascular control). In stage 4, microbiological control is crucial and severe infections need intravenous antibacterial therapy, and urgent assessment of the need for surgical drainage and debridement. Without urgent treatment, severe infections will progress to necrosis. In stage 5, necrosis can be divided into wet and dry necrosis. Wet necrosis in neuropathic feet requires intravenous antibacterials and surgical debridement, and wet necrosis in neuroischaemic feet also needs vascular reconstruction. Aggressive management of diabetic foot ulceration will reduce the number of feet proceeding to infection and necrosis, and thus reduce the number of major amputations in diabetic patients.

Entities:  

Mesh:

Year:  2006        PMID: 16740006     DOI: 10.2165/00003495-200666070-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  69 in total

1.  Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial.

Authors:  David G Armstrong; Lawrence A Lavery
Journal:  Lancet       Date:  2005-11-12       Impact factor: 79.321

2.  Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.

Authors:  E B Jude; P L Selby; J Burgess; P Lilleystone; E B Mawer; S R Page; M Donohoe; A V Foster; M E Edmonds; A J Boulton
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

Review 3.  A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. I: prevention.

Authors:  J Mason; C O'Keeffe; A McIntosh; A Hutchinson; A Booth; R J Young
Journal:  Diabet Med       Date:  1999-10       Impact factor: 4.359

4.  Which diabetic patients should receive podiatry care? An objective analysis.

Authors:  M McGill; L Molyneaux; D K Yue
Journal:  Intern Med J       Date:  2005-08       Impact factor: 2.048

Review 5.  The role of distal arterial reconstruction in patients with diabetic foot ischemia.

Authors:  Christos Lioupis
Journal:  Int J Low Extrem Wounds       Date:  2005-03       Impact factor: 2.057

6.  Evaluation of a diabetic foot screening and protection programme.

Authors:  C J McCabe; R C Stevenson; A M Dolan
Journal:  Diabet Med       Date:  1998-01       Impact factor: 4.359

7.  Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.

Authors:  G Pellizzer; M Strazzabosco; S Presi; F Furlan; L Lora; P Benedetti; M Bonato; G Erle; F de Lalla
Journal:  Diabet Med       Date:  2001-10       Impact factor: 4.359

Review 8.  New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies.

Authors:  R Eldor; I Raz; A Ben Yehuda; A J M Boulton
Journal:  Diabet Med       Date:  2004-11       Impact factor: 4.359

9.  Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria.

Authors:  S J Rith-Najarian; T Stolusky; D M Gohdes
Journal:  Diabetes Care       Date:  1992-10       Impact factor: 19.112

10.  Larval therapy--an effective method of ulcer debridement.

Authors:  H Wolff; C Hansson
Journal:  Clin Exp Dermatol       Date:  2003-03       Impact factor: 3.470

View more
  6 in total

1.  Differentiating diabetic foot ulcers that are unlikely to heal by 12 weeks following achieving 50% percent area reduction at 4 weeks.

Authors:  Robert A Warriner; Robert J Snyder; Matthew H Cardinal
Journal:  Int Wound J       Date:  2011-09-23       Impact factor: 3.315

2.  Implications of Antimicrobial Combinations in Complex Wound Biofilms Containing Fungi.

Authors:  Eleanor M Townsend; Leighann Sherry; Ryan Kean; Donald Hansom; William G Mackay; Craig Williams; John Butcher; Gordon Ramage
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Multidisciplinary approach to the diagnosis and management of patients with peripheral arterial disease.

Authors:  Craig M Walker; Frank T Bunch; Nick G Cavros; Eric J Dippel
Journal:  Clin Interv Aging       Date:  2015-07-10       Impact factor: 4.458

4.  Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation.

Authors:  Abubakr H Widatalla; Seif Eidin I Mahadi; Mohamed A Shawer; Hagir A Elsayem; Mohamed E Ahmed
Journal:  Int J Diabetes Dev Ctries       Date:  2009-01

5.  Can ultrasound measures of intrinsic foot muscles and plantar soft tissues predict future diabetes-related foot disease? A systematic review.

Authors:  Troy Morrison; Sara Jones; Ryan S Causby; Kerry Thoirs
Journal:  PLoS One       Date:  2018-06-15       Impact factor: 3.240

6.  Effect of contact with podiatry in a team approach context on diabetic foot ulcer and lower extremity amputation: systematic review and meta-analysis.

Authors:  Virginie Blanchette; Magali Brousseau-Foley; Lyne Cloutier
Journal:  J Foot Ankle Res       Date:  2020-03-20       Impact factor: 2.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.